OP0053 Inflammatory disorders associated with trisomy 8 myelodysplastic syndromes : french retrospective case control study
2018
Objectives We report myelodysplastic syndrome (MDS)-associated systemic inflammatory and autoimmune diseases (IADs) with cytogenetic trisomy 8, and describe their outcome, treatments efficacy and impact on MDS survival in a French multicenter retrospective study. Methods In this study, 21 patients with trisomy 8-MDS and IADs were analysed and compared to 103 MDS patients with trisomy 8 without IADs. Results The median age was 67 [59 – 80] years and the male/female ratio 0.9. The IADs were Behcet’s or Behcet’s-like disease in 11 (52%) cases, inflammatory arthritis in 4 (19%) cases, Sjogren’s syndrome, autoimmune hemolytic anaemia, aseptic abscesses, polyarterits nodosa, Sweet’s syndrome and unclassified vasculitis in one case each. Trisomy 8 karyotype was isolated in 8 cases (38%) and associated with other abnormalities in remaining cases. Seventeen (81%) IADs patients were treated (88% with steroids) with complete and partial response in 35% and 47%, respectively. A second-line therapy was required for steroid dependence or relapse in 38% of cases. The effect of MDS treatment on IADs could be assessed in 7 patients treated with Azacytidine : 5/13 (38%) achieved remission and 2/13 (15%) partial response of IADs. Compared with 103 trisomy 8-MDS/CMML patients without IADs, IADs patients were more often non-Caucasian (p=0.004), MDS subtype tended to be more frequently CRDM (p=0.09) and had more often a poor karyotype (p Conclusions The spectrum of IADs associated to trisomy 8-MDS is dominated by Behcet’s disease, but may also be other various immune disorders. Steroid therapy is often effective, but sparing therapies are mostly necessary. Disclosure of Interest None declared
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI